Fabrazyme Injection, Powder, Lyophilized, For Solution
Product Images NDC 58468-0041

Fabrazyme is a prescription medicine in the form of a single-dose vial, containing 5mg of agalsidase beta for intravenous infusion only. The medication is intended to be used immediately, with any unused portion to be discarded. The vial contains a solution of agalidase beta, enzymes and other compounds. After reconstitution, it creates a solution for IV infusion. It is recommended to store Fabrazyme in refrigerated conditions and not to be frozen or shaken. It is free of preservatives and complies with the US standard of Potency. Genzyme Corporation produces Fabrazyme under its registered trademark. Please read the packaging insert before use.*

This is a product description for Fabrazyme®, a medication that contains agalsidase beta for intravenous infusion only. It comes in a single-dose vial that should be discarded if any portion remains unused. The instructions state that it should be stored refrigerated and not be frozen or shaken. Each vial contains 37 mg of agalsidase beta, 22 mg of Mannitol, Sodium Phosphate Monobasic, and Manohydrate 204 mg. It also has 552 g of fabrazyme and a 74 ml reconstituted solution. The text indicates that it is manufactured by Genzyme Corporation and does not contain any preservatives. The product label includes a Datamatrix code, a lot number, and an expiration date.*